BioAdaptives Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-1.6M | $-899.2K | $-712.5K | $-895.6K | $-1.0M | $-847.2K | $-238.9K | $-1.4M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $4.0K | $0 | — | — | — | — | — | — |
| Amortization | $0 | $1.9K | $28.2K | $62.1K | $133.8K | — | — | — |
| Stock-Based Compensation | $28.7K | — | — | $0 | $163.9K | $47.1K | $0 | $272.7K |
| Net Cash from Operating Activities | $-516.0K | $-249.5K | $-223.8K | $-227.3K | $-158.7K | $-106.9K | $-168.1K | $-420.1K |
| Investing Activities | ||||||||
| Capital Expenditures | $18.0K | $0 | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-18.0K | $0 | — | — | — | — | — | $32.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $555.0K | $326.2K | $259.1K | $169.7K | $237.0K | $99.2K | $124.2K | $426.0K |
| Net Change in Cash | — | — | — | $-57.5K | $78.3K | $-7.7K | — | — |
| Free Cash Flow | $-534.0K | $-249.5K | — | — | — | — | — | — |